# 2017 A/H7N9 IIV Revaccination

> **NCT03738241** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 304 (actual)

## Conditions studied

- Avian Influenza
- Influenza Immunisation

## Interventions

- **BIOLOGICAL:** A/H7N9
- **DRUG:** AS03
- **OTHER:** Phosphate Buffered Saline (PBS) diluent

## Key facts

- **NCT ID:** NCT03738241
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2020-06-19
- **Final completion:** 2020-06-19
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2021-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738241, "2017 A/H7N9 IIV Revaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03738241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*